Analytical Data
-
基因名
CDR2
- Application
-
别名
Major Yo paraneoplastic antigen;Paraneoplastic cerebellar degeneration-associated antigen
-
种属
Human
-
表达系统
E. coli
-
标签
N- His
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q01850
-
表达区间
1-454aa
-
分子量
55.9 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
CDR2 (Calcium-dependent Regulator 2) is a protein that plays a pivotal role in calcium signaling pathways, which are essential for various cellular processes including muscle contraction, neurotransmitter release, and gene expression. The study of CDR2 and its recombinant forms has gained attention due to its potential implications in understanding calcium homeostasis and its dysregulation in diseases such as cancer and neurodegenerative disorders. The ability to produce CDR2 as a recombinant protein allows researchers to investigate its functional properties, interaction with other cellular proteins, and the molecular mechanisms underlying its effects on calcium signaling. Furthermore, recombinant CDR2 can serve as a valuable tool for therapeutic development, offering insights into novel treatment strategies aimed at modulating calcium-related pathways. By employing techniques such as site-directed mutagenesis, researchers can explore the structure-function relationships of CDR2, providing a deeper understanding of its role in health and disease. Overall, the research on CDR2 recombinant protein is crucial not only for basic science but also for the development of targeted therapies that address calcium signaling anomalies in various pathological conditions.
